Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 16;24(1):193.
doi: 10.1186/s12889-024-17739-z.

Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria

Affiliations

Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria

F A Magaji et al. BMC Public Health. .

Abstract

Background: High HIV prevalence, and lack of organized screening for the indigent population receiving care and treatment within HIV clinics in low-resource settings increases cervical cancer incidence. We sought to determine predictors of cervical precancer in women living with HIV and receiving cervical cancer screening in Jos, Nigeria.

Methods: A cross-sectional study of women living with HIV and receiving care and treatment in adult HIV/AIDS clinics in Jos-Metropolis, Nigeria between June 2020 and April 2023. Ethical approvals were obtained from the ethics committee in Jos, Nigeria and Northwestern University IRB, USA. Informed consent was obtained from eligible participants, and data on socio-demographics, cancer risk factors, and cytology reports were collected. The outcome variables were cervical precancer lesions. The independent variables were prior Pap smear status, socio-demographics, income, educational, and other reproductive health factors. Descriptive statistics was done to obtain means ± sd, frequencies, and percentages for the variables. Univariate and bivariate analyses were done to determine predictors of cervical dysplasia. Analyses were performed using R software.

Results: Of 957 women screened, 570 were living with HIV and 566 women had cytology report and were included in the final analysis. The mean age was 45.08 ± 8.89 years and 81.6% had no prior evidence of Pap test (under-screened). Prevalence of cervical dysplasia was 24% (mild and severe dysplasia were 12.9% and 11.1%, respectively). Age above 45 years (aOR = 3.48, p = 0.009), postmenopausal status (aOR = 7.69, p = 0.000), and women with no history of prior IUCD use (aOR = 5.94, p = 0.0001), were predictors for severe dysplasia. Women who had history of STI (aOR = 0.17, p = 0.000), prior use of IUCD (aOR = 0.32, p = 0.004), prior use of condom (aOR = 2.50, p = 0.003) and had co-morbidities (aOR = 0.46, p = 0.009) were more likely to have had a Pap test in the past.

Conclusions: The majority of indigent women receiving care at HIV clinics had their first Pap test screening, and lack of organized screening among older and post-menopausal women with HIV, puts women at a higher risk of developing severe cervical precancer lesions.

Keywords: Adult HIV-clinic; Cervical precancer and cancer; Indigent women; Jos-Nigeria; Pap test.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Box Plot of Age at Pap test in women living with HIV in Jos Nigeria
Fig. 2
Fig. 2
Receiver Operator Characteristic (ROC) Curves for the Predictive Model of Women who had Severe Dysplasia Area Under the curve (AUC): 0.86
Fig. 3
Fig. 3
Receiver Operator Characteristic (ROC) Curves for the Predictive Model of Women with prior Pap test Area Under the Curve (AUC): 0.84

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Torre LA, Islami F, Siegel RL, et al. Global cancer in women: Burden and Trends. Cancer Epidemiol Biomakers Prev. 2017;26:444. doi: 10.1158/1055-9965.EPI-16-0858. - DOI - PubMed
    1. Rahatgaonkar VG, Deshpande AA, Oka GA. Screening for cervical cancer in HIV-infected women: a review of literature. Indian J Cancer. 2021;58(3):317–25. - PubMed
    1. Barnes A, Betts AC, Borton EK, Sanders JM, Pruitt SL, Werner C, et al. Cervical cancer screening among HIV-infected women in a urban, United States safety-net healthcare system. AIDS. 2018;32:13. doi: 10.1097/QAD.0000000000001881. - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed

Publication types